ALVR

ALVR

USD

AlloVir Inc. Common Stock

$9.810+0.260 (2.723%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

No hay datos de gráfico disponibles

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$9.550

Máximo

$10.320

Mínimo

$9.550

Volumen

N/A

Fundamentos de la Empresa

Capitalización de Mercado

49.5M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.02M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $7.96Actual $9.810Máximo $24.15

Noticias Relacionadas

GlobeNewswire

Kalaris and AlloVir Announce Stockholder Approval of Merger

PALO ALTO, Calif. and LEXINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. ("Kalaris"), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of

Ver más
Kalaris and AlloVir Announce Stockholder Approval of Merger
PR Newswire

SHAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of ALVR, IPG, AVAV, WMPN to Act Now

Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by...

Ver más
SHAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of ALVR, IPG, AVAV, WMPN to Act Now
PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IPG, ALVR, WMPN, AVAV on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Ver más
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IPG, ALVR, WMPN, AVAV on Behalf of Shareholders

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.